Literature DB >> 19782454

Obesity and change in estimated GFR among older adults.

Ian H de Boer1, Ronit Katz, Linda F Fried, Joachim H Ix, Jose Luchsinger, Mark J Sarnak, Michael G Shlipak, David S Siscovick, Bryan Kestenbaum.   

Abstract

BACKGROUND: The prevalence of chronic kidney disease is growing most rapidly among older adults; however, determinants of impaired kidney function in this population are not well understood. Obesity assessed in midlife has been associated with chronic kidney disease. STUDY
DESIGN: Cohort study. SETTING & PARTICIPANTS: 4,295 participants in the community-based Cardiovascular Health Study, aged >or= 65 years. PREDICTORS: Body mass index, waist circumference, and fat mass measured using bioelectrical impedance. OUTCOME: Change in glomerular filtration rate (GFR) during 7 years of follow-up. MEASUREMENTS: Longitudinal estimates of GFR calculated using the 4-variable Modification of Diet in Renal Disease (MDRD) Study equation.
RESULTS: Estimated GFR decreased by an average of 0.4 +/- 3.6 mL/min/1.73 m(2)/y, and rapid GFR loss (>3 mL/min/1.73 m(2)/y) occurred in 693 participants (16%). Baseline body mass index, waist circumference, and fat mass were each associated with increased risk of rapid GFR loss: ORs, 1.19 (95% CI, 1.09-1.30) per 5 kg/m(2), 1.25 (95% CI, 1.16-1.36) per 12 cm, and 1.14 (95% CI, 1.05-1.24) per 10 kg after adjustment for age, sex, race, and smoking. The magnitude of increased risk was larger for participants with estimated GFR < 60 mL/min/1.73 m(2) at baseline (P for interaction < 0.05). Associations were substantially attenuated by further adjustment for diabetes, hypertension, and C-reactive protein level. Obesity measurements were not associated with change in GFR estimated using serum cystatin C level. LIMITATIONS: Few participants with advanced chronic kidney disease at baseline, no direct GFR measurements.
CONCLUSION: Obesity may be a modifiable risk factor for the development and progression of kidney disease in older adults.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19782454      PMCID: PMC2787647          DOI: 10.1053/j.ajkd.2009.07.018

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  36 in total

Review 1.  Indexing glomerular filtration rate for body surface area in obese patients is misleading: concept and example.

Authors:  Pierre Delanaye; Régis P Radermecker; Marcelle Rorive; Gisèle Depas; Jean Marie Krzesinski
Journal:  Nephrol Dial Transplant       Date:  2005-07-19       Impact factor: 5.992

Review 2.  Obesity, proteinuria and progression of renal failure.

Authors:  Manuel Praga; Enrique Morales
Journal:  Curr Opin Nephrol Hypertens       Date:  2006-09       Impact factor: 2.894

3.  Obesity and prevalent and incident CKD: the Hypertension Detection and Follow-Up Program.

Authors:  Holly Kramer; Amy Luke; Anil Bidani; Guichan Cao; Richard Cooper; Dan McGee
Journal:  Am J Kidney Dis       Date:  2005-10       Impact factor: 8.860

4.  Association between body mass index and CKD in apparently healthy men.

Authors:  Rebecca P Gelber; Tobias Kurth; Annamaria T Kausz; Joann E Manson; Julie E Buring; Andrew S Levey; J Michael Gaziano
Journal:  Am J Kidney Dis       Date:  2005-11       Impact factor: 8.860

5.  GFR estimation using cystatin C is not independent of body composition.

Authors:  Jamie Macdonald; Samuele Marcora; Mahdi Jibani; Gareth Roberts; Mick Kumwenda; Ruth Glover; Jeffrey Barron; Andrew Lemmey
Journal:  Am J Kidney Dis       Date:  2006-11       Impact factor: 8.860

Review 6.  Obesity in older adults: technical review and position statement of the American Society for Nutrition and NAASO, The Obesity Society.

Authors:  Dennis T Villareal; Caroline M Apovian; Robert F Kushner; Samuel Klein
Journal:  Am J Clin Nutr       Date:  2005-11       Impact factor: 7.045

7.  Cystatin C and the risk of death and cardiovascular events among elderly persons.

Authors:  Michael G Shlipak; Mark J Sarnak; Ronit Katz; Linda F Fried; Stephen L Seliger; Anne B Newman; David S Siscovick; Catherine Stehman-Breen
Journal:  N Engl J Med       Date:  2005-05-19       Impact factor: 91.245

8.  Body mass index and risk for end-stage renal disease.

Authors:  Chi-yuan Hsu; Charles E McCulloch; Carlos Iribarren; Jeanne Darbinian; Alan S Go
Journal:  Ann Intern Med       Date:  2006-01-03       Impact factor: 25.391

9.  Central obesity, incident microalbuminuria, and change in creatinine clearance in the epidemiology of diabetes interventions and complications study.

Authors:  Ian H de Boer; Shalamar D Sibley; Bryan Kestenbaum; Joshua N Sampson; Bessie Young; Patricia A Cleary; Michael W Steffes; Noel S Weiss; John D Brunzell
Journal:  J Am Soc Nephrol       Date:  2006-12-06       Impact factor: 10.121

10.  Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement.

Authors:  Eric L Knight; Jacobien C Verhave; Donna Spiegelman; Hans L Hillege; Dick de Zeeuw; Gary C Curhan; Paul E de Jong
Journal:  Kidney Int       Date:  2004-04       Impact factor: 10.612

View more
  46 in total

1.  Relationship between serum cystatin C and hypertension among US adults without clinically recognized chronic kidney disease.

Authors:  Anoop Shankar; Srinivas Teppala
Journal:  J Am Soc Hypertens       Date:  2011-04-17

2.  Healthy lifestyle and risk of kidney disease progression, atherosclerotic events, and death in CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study.

Authors:  Ana C Ricardo; Cheryl A Anderson; Wei Yang; Xiaoming Zhang; Michael J Fischer; Laura M Dember; Jeffrey C Fink; Anne Frydrych; Nancy G Jensvold; Eva Lustigova; Lisa C Nessel; Anna C Porter; Mahboob Rahman; Julie A Wright Nunes; Martha L Daviglus; James P Lash
Journal:  Am J Kidney Dis       Date:  2014-11-20       Impact factor: 8.860

3.  Predicting Risk of RRT in Patients with CKD.

Authors:  Morgan E Grams; Josef Coresh
Journal:  Clin J Am Soc Nephrol       Date:  2016-12-27       Impact factor: 8.237

4.  The association of adiposity with kidney function decline among HIV-infected adults: findings from the Fat Redistribution and Metabolic Changes in HIV Infection (FRAM) study.

Authors:  A Malkina; R Scherzer; M G Shlipak; P Bacchetti; P C Tien; C Grunfeld; L Kosmiski; C A Peralta
Journal:  HIV Med       Date:  2014-09-23       Impact factor: 3.180

5.  CKD Self-management: Phenotypes and Associations With Clinical Outcomes.

Authors:  Sarah J Schrauben; Jesse Y Hsu; Sylvia E Rosas; Bernard G Jaar; Xiaoming Zhang; Rajat Deo; Georges Saab; Jing Chen; Swati Lederer; Radhika Kanthety; L Lee Hamm; Ana C Ricardo; James P Lash; Harold I Feldman; Amanda H Anderson
Journal:  Am J Kidney Dis       Date:  2018-03-24       Impact factor: 8.860

6.  Higher biomarker-calibrated protein intake is not associated with impaired renal function in postmenopausal women.

Authors:  Jeannette M Beasley; Aaron K Aragaki; Andrea Z LaCroix; Marian L Neuhouser; Lesley F Tinker; Jane A Cauley; Kristine E Ensrud; Rebecca D Jackson; Ross L Prentice
Journal:  J Nutr       Date:  2011-06-08       Impact factor: 4.798

7.  Body mass index is an independent predictive factor for kidney function evaluated by glomerular filtration rate in a community-dwelling population.

Authors:  Yuanyuan Duan; Xiaona Wang; Jiao Zhang; Ping Ye; Ruihua Cao; Xu Yang; Yongyi Bai; Hongmei Wu
Journal:  Eat Weight Disord       Date:  2017-09-04       Impact factor: 4.652

8.  Overweight and Obesity Are Predictors of Progression in Early Autosomal Dominant Polycystic Kidney Disease.

Authors:  Kristen L Nowak; Zhiying You; Berenice Gitomer; Godela Brosnahan; Vicente E Torres; Arlene B Chapman; Ronald D Perrone; Theodore I Steinman; Kaleab Z Abebe; Frederic F Rahbari-Oskoui; Alan S L Yu; Peter C Harris; Kyongtae T Bae; Marie Hogan; Dana Miskulin; Michel Chonchol
Journal:  J Am Soc Nephrol       Date:  2017-11-08       Impact factor: 10.121

9.  Kidney function decline in metformin versus sulfonylurea initiators: assessment of time-dependent contribution of weight, blood pressure, and glycemic control.

Authors:  Adriana M Hung; Christianne L Roumie; Robert A Greevy; Xulei Liu; Carlos G Grijalva; Harvey J Murff; Marie R Griffin
Journal:  Pharmacoepidemiol Drug Saf       Date:  2013-06       Impact factor: 2.890

10.  Risk Factors for Rapid Kidney Function Decline Among African Americans: The Jackson Heart Study (JHS).

Authors:  Bessie A Young; Ronit Katz; L Ebony Boulware; Bryan Kestenbaum; Ian H de Boer; Wei Wang; Tibor Fülöp; Nisha Bansal; Cassianne Robinson-Cohen; Michael Griswold; Neil R Powe; Jonathan Himmelfarb; Adolfo Correa
Journal:  Am J Kidney Dis       Date:  2016-04-09       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.